Back to search

Article

N-acylethanolamine acid amide hydrolase is a novel target for drugs against SARS-CoV-2 and Zika virus

2022-02-09

Abstract excerpt

Several compounds have been tested against SARS-CoV-2; at present, COVID-19 treatments decrease the deleterious inflammatory response and acute lung injury. However, the best therapeutic response would be expected by combining anti-inflammatory properties, while concomitantly blocking viral replication. These combined effects should drastically reduce both infection rate and severe complications induced by novel S...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d3d127f2-ef59-5a81-a5a4-bb087fa05f12
DOI
10.1101/2022.02.08.479661
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
N-acylethanolamine acid amide hydrolase is a novel target for drugs against SARS-CoV-2 and Zika virusDOI 10.1101/2022.02.08.479661
Select a neighboring publication to make it the new centre.